JPRN-UMIN000022615已完成未知
Efficacy of ipragliflozin on diabetic nephropathy in patients with type 2 diabetes - Efficacy of ipragliflozin on diabetic nephropathy in patients with type 2 diabetes
Ogawa Red Cross Hospital0 个研究点目标入组 50 人开始时间: 2016年6月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have history or current serious diabetic complication. 2. Patients that insulin dependence is suspected. 3. Patients who have history or current cardiac failure (New York Heart Association Class III or IV), myocardial infarction or cerebrovascular disorder. 4. Patients whose eGFR lower than 45 mL/min/1.73m2, serum creatinine higher than 1.5 mg/dL. 5. Patients who have hepatic dysfunction.
研究者
相似试验
已完成
不适用
ong-term effects of ipragliflozin on diabetic nephropathy and blood pressure in patients with type 2 diabetesType 2 diabetes with diabetic nephropathyJPRN-UMIN000031157Ogawa Red Cross Hospital50
招募中
不适用
Efficacy of Ipragliflozin in type 1 diabetic patientstype 1 diabetic patientsJPRN-UMIN000036038Ise Red Cross Hospital Department of Metabolic Diseases50
招募中
3 期
Efficacy of anti diabetic drug (Dapagliflozin) in patients with Diabetic periphral neuropathyCTRI/2022/06/043236Postgraduate Institute of Medical Education Research
已完成
不适用
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
尚未招募
4 期
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160